A Comprehensive Scientific Review of the Synthetic Thymosin Beta-4 Fragment is TB-500

Author : Albertine Smith | Published On : 19 Apr 2026

Due to its claimed biological activities, including elastic bound, angiogenesis, and tissue repair, this protein piece has attracted considerable research interest.

The U.S. Food and Drug Administration( FDA) has not approved TB500 for human medical use because it is a research chemical.

Important questions have been raised about whether the family compound or its compounds are responsible for the biological activities that have been investigated in new pharmacokinetic and pharmacodynamic analysis.